These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15364092)

  • 1. Data mining techniques for cancer detection using serum proteomic profiling.
    Li L; Tang H; Wu Z; Gong J; Gruidl M; Zou J; Tockman M; Clark RA
    Artif Intell Med; 2004 Oct; 32(2):71-83. PubMed ID: 15364092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial neural networks and decision tree model analysis of liver cancer proteomes.
    Luk JM; Lam BY; Lee NP; Ho DW; Sham PC; Chen L; Peng J; Leng X; Day PJ; Fan ST
    Biochem Biophys Res Commun; 2007 Sep; 361(1):68-73. PubMed ID: 17644064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A data review and re-assessment of ovarian cancer serum proteomic profiling.
    Sorace JM; Zhan M
    BMC Bioinformatics; 2003 Jun; 4():24. PubMed ID: 12795817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer?
    Sandoval JA; Dobrolecki LE; Huang J; Grosfeld JL; Hickey RJ; Malkas LH
    J Pediatr Surg; 2006 Apr; 41(4):639-46; discussion 639-46. PubMed ID: 16567169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
    Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
    Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
    Jackson D; Craven RA; Hutson RC; Graze I; Lueth P; Tonge RP; Hartley JL; Nickson JA; Rayner SJ; Johnston C; Dieplinger B; Hubalek M; Wilkinson N; Perren TJ; Kehoe S; Hall GD; Daxenbichler G; Dieplinger H; Selby PJ; Banks RE
    Clin Cancer Res; 2007 Dec; 13(24):7370-9. PubMed ID: 18094419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer diagnosis with complementary learning fuzzy neural network.
    Tan TZ; Quek C; Ng GS; Razvi K
    Artif Intell Med; 2008 Jul; 43(3):207-22. PubMed ID: 18541419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
    Hong YJ; Wang XD; Shen D; Zeng S
    Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of early relapse in ovarian cancer using serum proteomic profiling.
    Oh JH; Gao J; Nandi A; Gurnani P; Knowles L; Schorge J
    Genome Inform; 2005; 16(2):195-204. PubMed ID: 16901102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
    Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
    Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of rough-based feature selection and RBF neural network for classification using gene expression data.
    Chiang JH; Ho SH
    IEEE Trans Nanobioscience; 2008 Mar; 7(1):91-9. PubMed ID: 18334459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feature extraction and dimensionality reduction for mass spectrometry data.
    Liu Y
    Comput Biol Med; 2009 Sep; 39(9):818-23. PubMed ID: 19646687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiple kernel support vector machine scheme for feature selection and rule extraction from gene expression data of cancer tissue.
    Chen Z; Li J; Wei L
    Artif Intell Med; 2007 Oct; 41(2):161-75. PubMed ID: 17851055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum proteomic profiles of the subjects with esophageal precancerous and cancerous lesions from Linzhou, an area with high incidence of esophageal cancer in Henan Province, Northern China].
    Wang LD; Wang DC; Zheng S; Fan ZM; Li JL; Feng CW; Zhang YR; Liu B; Gao SS; He X; Feng XS
    Ai Zheng; 2006 May; 25(5):549-54. PubMed ID: 16687072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.